Annual Total Liabilities
$817.37 M
+$369.23 M+82.39%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual total liabilities is $817.37 million, with the most recent change of +$369.23 million (+82.39%) on December 31, 2023.
- During the last 3 years, IRWD annual total liabilities has risen by +$320.77 million (+64.59%).
- IRWD annual total liabilities is now at all-time high.
Performance
IRWD Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$700.85 M
-$16.49 M-2.30%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly total liabilities is $700.85 million, with the most recent change of -$16.49 million (-2.30%) on September 30, 2024.
- Over the past year, IRWD quarterly total liabilities has stayed the same.
- IRWD quarterly total liabilities is now -26.23% below its all-time high of $950.00 million, reached on June 30, 2023.
Performance
IRWD Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
IRWD Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.4% | 0.0% |
| 3 y3 years | +64.6% | +34.5% |
| 5 y5 years | +54.7% | +34.5% |
IRWD Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.4% | -26.2% | +58.3% |
| 5 y | 5-year | at high | +82.4% | -26.2% | +58.3% |
| alltime | all time | at high | +852.0% | -26.2% | +988.1% |
Ironwood Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $700.85 M(-2.3%) |
| Jun 2024 | - | $717.35 M(-6.8%) |
| Mar 2024 | - | $769.34 M(-5.9%) |
| Dec 2023 | $817.37 M(+82.4%) | $817.37 M(-3.8%) |
| Sep 2023 | - | $849.74 M(-10.6%) |
| Jun 2023 | - | $950.00 M(+111.9%) |
| Mar 2023 | - | $448.43 M(+0.1%) |
| Dec 2022 | $448.14 M(-14.0%) | $448.14 M(-0.3%) |
| Sep 2022 | - | $449.28 M(+1.5%) |
| Jun 2022 | - | $442.81 M(-21.7%) |
| Mar 2022 | - | $565.60 M(+8.6%) |
| Dec 2021 | $521.02 M(+4.9%) | $521.02 M(+4.3%) |
| Sep 2021 | - | $499.43 M(+0.8%) |
| Jun 2021 | - | $495.46 M(+1.3%) |
| Mar 2021 | - | $489.15 M(-1.5%) |
| Dec 2020 | $496.60 M(+0.1%) | $496.60 M(+2.1%) |
| Sep 2020 | - | $486.42 M(+1.3%) |
| Jun 2020 | - | $480.39 M(+1.0%) |
| Mar 2020 | - | $475.56 M(-4.1%) |
| Dec 2019 | $496.00 M(-6.1%) | $496.00 M(+1.8%) |
| Sep 2019 | - | $487.39 M(-8.9%) |
| Jun 2019 | - | $535.09 M(-10.9%) |
| Mar 2019 | - | $600.72 M(+13.7%) |
| Dec 2018 | $528.42 M(-11.3%) | $528.42 M(-13.9%) |
| Sep 2018 | - | $613.95 M(-7.3%) |
| Jun 2018 | - | $662.17 M(+12.4%) |
| Mar 2018 | - | $589.15 M(-1.1%) |
| Dec 2017 | $595.83 M(-7.4%) | $595.83 M(-7.3%) |
| Sep 2017 | - | $642.66 M(-8.2%) |
| Jun 2017 | - | $700.21 M(+4.2%) |
| Mar 2017 | - | $671.68 M(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $643.11 M(+22.7%) | $643.11 M(-4.4%) |
| Sep 2016 | - | $672.52 M(+8.7%) |
| Jun 2016 | - | $618.83 M(+20.8%) |
| Mar 2016 | - | $512.39 M(-2.2%) |
| Dec 2015 | $524.00 M(+117.6%) | $524.00 M(+2.1%) |
| Sep 2015 | - | $512.97 M(-0.1%) |
| Jun 2015 | - | $513.66 M(+116.4%) |
| Mar 2015 | - | $237.37 M(-1.4%) |
| Dec 2014 | $240.77 M(+0.0%) | $240.77 M(+1.2%) |
| Sep 2014 | - | $238.02 M(+3.8%) |
| Jun 2014 | - | $229.23 M(-0.3%) |
| Mar 2014 | - | $229.93 M(-4.5%) |
| Dec 2013 | $240.74 M(+180.4%) | $240.74 M(-0.4%) |
| Sep 2013 | - | $241.63 M(-1.2%) |
| Jun 2013 | - | $244.62 M(-8.2%) |
| Mar 2013 | - | $266.57 M(+210.5%) |
| Dec 2012 | $85.86 M(-13.4%) | $85.86 M(+33.3%) |
| Sep 2012 | - | $64.41 M(-19.4%) |
| Jun 2012 | - | $79.88 M(-6.1%) |
| Mar 2012 | - | $85.03 M(-14.2%) |
| Dec 2011 | $99.12 M(-30.1%) | $99.12 M(-7.0%) |
| Sep 2011 | - | $106.55 M(-10.9%) |
| Jun 2011 | - | $119.61 M(-6.1%) |
| Mar 2011 | - | $127.44 M(-10.1%) |
| Dec 2010 | $141.81 M(-69.2%) | $141.81 M(-4.5%) |
| Jun 2010 | - | $148.53 M(-0.5%) |
| Mar 2010 | - | $149.33 M(-67.6%) |
| Dec 2009 | $460.79 M(+24.9%) | $460.79 M(+239.7%) |
| Sep 2009 | - | $135.64 M(-63.2%) |
| Dec 2008 | $368.78 M(+17.3%) | $368.78 M |
| Dec 2007 | $314.28 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual total liabilities year-on-year change?
- What is Ironwood Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly total liabilities year-on-year change?
What is Ironwood Pharmaceuticals annual total liabilities?
The current annual total liabilities of IRWD is $817.37 M
What is the all time high annual total liabilities for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual total liabilities is $817.37 M
What is Ironwood Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, IRWD annual total liabilities has changed by +$369.23 M (+82.39%)
What is Ironwood Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of IRWD is $700.85 M
What is the all time high quarterly total liabilities for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly total liabilities is $950.00 M
What is Ironwood Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, IRWD quarterly total liabilities has changed by $0.00 (0.00%)